First Trust Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.62M Buy
+659,731
New +$2.75M ﹤0.01% 1918
2024
Q2
– Sell
-81,912
Closed -$713K – 2376
2024
Q1
$713K Sell
81,912
-217,333
-73% -$2.64M ﹤0.01% 2069
2023
Q4
$3.42M Buy
+299,245
New +$2.96M ﹤0.01% 1488
2023
Q3
– Sell
-228,999
Closed -$2.44M – 2434
2023
Q2
$2.44M Buy
228,999
+59,658
+35% +$641K ﹤0.01% 1605
2023
Q1
$1.78M Sell
169,341
-227,512
-57% -$2.55M ﹤0.01% 1726
2022
Q4
$4.92M Sell
396,853
-105,809
-21% -$1.2M 0.01% 1205
2022
Q3
$5.21M Buy
502,662
+134,558
+37% +$1.53M 0.01% 1171
2022
Q2
$4.24M Sell
368,104
-90,899
-20% -$1.07M 0.01% 1321
2022
Q1
$5.77M Buy
459,003
+181,729
+66% +$2.08M 0.01% 1249
2021
Q4
$3.23M Buy
277,274
+149,167
+116% +$1.83M ﹤0.01% 1587
2021
Q3
$1.67M Buy
+128,107
New +$1.66M ﹤0.01% 1831
2021
Q2
– Sell
-47,780
Closed -$534K – 2517
2021
Q1
$534K Sell
47,780
-71,435
-60% -$755K ﹤0.01% 2194
2020
Q4
$1.36M Buy
119,215
+8,405
+8% +$92K ﹤0.01% 1763
2020
Q3
$997K Sell
110,810
-85,712
-44% -$852K ﹤0.01% 1764
2020
Q2
$2.03M Sell
196,522
-31,728
-14% -$325K ﹤0.01% 1368
2020
Q1
$2.3M Buy
228,250
+214,954
+1,617% +$2.53M 0.01% 1208
2019
Q4
$177K Sell
13,296
-31,645
-70% -$349K ﹤0.01% 2333
2019
Q3
$386K Sell
44,941
-24,143
-35% -$235K ﹤0.01% 2209
2019
Q2
$756K Buy
+69,084
New +$774K ﹤0.01% 1964
2019
Q1
– Sell
-130,059
Closed -$1.13M – 2429
2018
Q4
$1.13M Sell
130,059
-77,311
-37% -$887K ﹤0.01% 1789
2018
Q3
$3.21M Buy
207,370
+147,916
+249% +$2.34M 0.01% 1394
2018
Q2
$952K Buy
+59,454
New +$880K ﹤0.01% 1956
2017
Q4
– Sell
-90,639
Closed -$1.2M – 2423
2017
Q3
$1.2M Sell
90,639
-22,471
-20% -$309K ﹤0.01% 1768
2017
Q2
$1.79M Buy
113,110
+19,125
+20% +$278K ﹤0.01% 1556
2017
Q1
$1.34M Sell
93,985
-70,151
-43% -$959K ﹤0.01% 1726
2016
Q4
$2.1M Buy
164,136
+32,782
+25% +$414K 0.01% 1420
2016
Q3
$1.75M Buy
131,354
+85,941
+189% +$1M 0.01% 1411
2016
Q2
$497K Buy
+45,413
New +$444K ﹤0.01% 1956

Other funds holding IRWD

First Trust Advisors's IRWD Position: Q3 2026 in Review

First Trust Advisors opened a new position in Ironwood Pharmaceuticals (IRWD) in Q3 2026: 659,731 shares worth $2.62M. The stake represents ﹤0.01% of the portfolio and ranks #1918 among its holdings. This is a return to the name: First Trust Advisors previously reported a position in IRWD as recently as Q1 2024.

First Trust Advisors first reported a position in IRWD in Q2 2016 and has held it in 28 quarters since. The position peaked at $5.77M in Q1 2022. 232 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • First Trust Advisors held 659,731 shares of Ironwood Pharmaceuticals worth $2.62M as of Q3 2026.
  • Ironwood Pharmaceuticals was a new First Trust Advisors position in Q3 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of First Trust Advisors's portfolio in Q3 2026, its #1918 holding.
  • First Trust Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2016 and has held it in 28 quarters since.
  • First Trust Advisors's Ironwood Pharmaceuticals position peaked at $5.77M in Q1 2022.
  • 232 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.